We are pleased to announce the 3rd Annual NYS Cannabinoids in Clinical Practice and Research Symposium, sponsored by the New York State Office of Cannabis Management, and co-hosted by Montefiore Einstein. This landmark event offers a unique opportunity for healthcare practitioners, public health professionals, researchers, and trainees to examine the full spectrum of cannabis science—from pre-clinical research to evidence-based clinical applications and population-level strategies for health equity and harm reduction. Together, we will explore what the science tells us about the biological mechanisms, therapeutic potential, and the real-world impacts of cannabis use across communities.
Presentation topics may include, but are not limited to, the following areas:
- Biology of the Endocannabinoid System
- Pharmacology of Cannabis
- Drug Interactions
- Routes of Administration and Dosing
- Cannabis and Substance Use Disorder
- Legal Considerations in Medical Cannabis
- Cannabis Regulation and Public Policy
- Cannabis and Public Health
- Cannabis Education
- Social Impact of Cannabis
- Potential Health Implications and Risks of Medical Cannabis
- Culturally Competent Cannabis Care
- Cannabis Plant Biology and Advanced Cultivation Techniques
- Cannabis Processing/Lab Testing/Techniques
- Any other symposium-relevant topic
- Clinical Implications of Cannabis Use Across Health Conditions:
- Alzheimer’s
- Autism
- Cancer and Cancer-Associated Side Effects
- Cannabis Hyperemesis Syndrome
- Chemotherapy-Induced Nausea and Vomiting
- Chronic Pain including Neuropathy
- Epilepsy
- HIV/AIDS including associated side effects
- Inflammatory Bowel Disease
- Mental Health and Mood Disorders
- Multiple Sclerosis
- Parkinson's Disease
- Palliative Care
- Rheumatoid Arthritis
- Sleep Dysregulation